Shang Yuqin, Zeng Yun, Zeng Yong
Department of Chemistry, University of Kansas, Lawrence, KS 66045.
College of Water Resource and Hydropower, Sichuan Agricultural University, Ya'an, Sichuan 625014, P.R. China.
Sci Rep. 2016 Feb 2;6:20297. doi: 10.1038/srep20297.
Protein glycosylation is one of the key processes that play essential roles in biological functions and dysfunctions. However, progress in glycomics has considerably lagged behind genomics and proteomics, due in part to the enormous challenges in analysis of glycans. Here we present a new integrated and automated microfluidic lectin barcode platform to substantially improve the performance of lectin array for focused glycomic profiling. The chip design and flow control were optimized to promote the lectin-glycan binding kinetics and speed of lectin microarray. Moreover, we established an on-chip lectin assay which employs a very simple blocking method to effectively suppress the undesired background due to lectin binding of antibodies. Using this technology, we demonstrated focused differential profiling of tissue-specific glycosylation changes of a biomarker, CA125 protein purified from ovarian cancer cell line and different tissues from ovarian cancer patients in a fast, reproducible, and high-throughput fashion. Highly sensitive CA125 detection was also demonstrated with a detection limit much lower than the clinical cutoff value for cancer diagnosis. This microfluidic platform holds the potential to integrate with sample preparation functions to construct a fully integrated "sample-to-answer" microsystem for focused differential glycomic analysis. Thus, our technology should present a powerful tool in support of rapid advance in glycobiology and glyco-biomarker development.
蛋白质糖基化是在生物功能和功能失调中发挥关键作用的关键过程之一。然而,糖组学的进展在很大程度上落后于基因组学和蛋白质组学,部分原因是聚糖分析面临巨大挑战。在此,我们展示了一种新型的集成自动化微流控凝集素条形码平台,以显著提高凝集素阵列在聚焦糖组分析中的性能。对芯片设计和流动控制进行了优化,以促进凝集素-聚糖结合动力学和凝集素微阵列的速度。此外,我们建立了一种芯片上凝集素检测方法,该方法采用非常简单的封闭方法,有效抑制由于抗体与凝集素结合产生的非预期背景。利用该技术,我们以快速、可重复和高通量的方式展示了对一种生物标志物组织特异性糖基化变化的聚焦差异分析,该生物标志物是从卵巢癌细胞系和卵巢癌患者的不同组织中纯化得到的CA125蛋白。还展示了高灵敏度的CA125检测,其检测限远低于癌症诊断的临床临界值。这个微流控平台有潜力与样品制备功能集成,构建一个用于聚焦差异糖组分析的完全集成的“样品到答案”微系统。因此,我们的技术应该为支持糖生物学和糖生物标志物开发的快速进展提供一个强大的工具。